References
- AXELSON, M. and SioVALL J., 1983, Formation of catechol estrogens by intestinal bacterial demethylation of 2-methoxyestrone. Biochimica et Biophysica Acta, 751, 1 62–1 65.
- MOLDEUS, P., HOGBERG, J. and ORRENIU S., 1978, Isolation and use of liver cells. Methods in Enzymology, 52, 60–71.
- NArTo, S. and NisiiimuRA, M., 1999, Pharmacokinetics and proposed metabolic pathways of BOF-4272, a sulfoxide-containing drug, based on in-vivo and in-vitro studies in rats. Pharmacy and Pharmacology Communications, 5, 123–131.
- NArTo, S., NisiiimuRA, M. and NOGAWA, H., 1999, Pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, after single intravenous or oral administration to male mice and rats. Journal of Pharmacy and Pharmacology, 51, 347–351.
- NisiumuRA, M., YAMAOKA, K., NAITO, S. and NAKAGAWA, T., 1996, Hepatic local disposition of a drug with high protein binding and high hepatic clearance using BOF-4272 as a model drug. Biological and Pharmaceutical Bulletin, 19, 1197–1202.
- NisiiimuRA, M., YAMAOKA, K., YASUI, H., NArTo, S. and NAKAGAWA, T., 1994, Local disposition of new xanthine oxidase/xanthine dehydrogenase inhibitor, BOF-4272, in rat liver. Biological and Pharmaceutical Bulletin, 17, 1301–1304.
- NisiiimuRA, M., YAMAOKA, K., YASUI, H., NAITO, S. and NAKAGAWA, T., 1995, Effect of temperature in perfusate on local hepatic disposition of BOF-4272, a new xanthine oxidase inhibitor. Biological and Pharmaceutical Bulletin, 18, 980–983.
- OICAMOTO, K., IwAmoTo, T. and NIsHiro, T., 1993, New tight binding inhibitors of xanthine oxidase. In Flavins and Flavoproteins (Berlin: Walter de Gruyter), pp. 731–734.
- OICAMOTO, K. and NISHINO, T., 1995, Mechanism of inhibition of xanthine oxidase with a new tight binding inhibitor. Journal of Biological Chemistry, 270, 7816–7821.
- RENWICK, A. G., EVANS, S. P., SWEATMAN, T. W., CUMBERLAND, J. and GEORGE, C. F., 1982, The role of the gut flora in the reduction of sulphinpyrazone in the rat. Biochemical Pharmacology, 31, 2649–2656.
- SATO, S., TATSUME, K. and Nisnitvo, T., 1991, A novel xanthine dehydrogenase inhibitor, BOF-4272. Advances in Experimental Medicine and Biology, 309A, 135–138.
- STRONG, H. A., RENWICK, A. G., GEORGE, C. F., Liu, Y. F. and HILL, M. J., 1987, The reduction of sulphinpyrazone and sulindac by intestinal bacteria. Xenobiotka, 17, 685–696.
- STRONG, H. A., WARNER, N. J., RENWICK, A. G. and GEORGE, C. F., 1985, Sulindac metabolism: The importance of an intact colon. Clinical Pharmacology and Therapeutics, 38, 387–393.
- Suzuxi, H., SUEMATSU, M., Ism, H., KATO, S., MIKI, H., MORI, M., IsurmuRA, Y., Nismvo, T. and TSUCHIYA, M., 1994, Prostaglandin El abrogates early reductive stress and zone-specific paradoxical oxidative injury in hypoperfused rat liver. Journal of Clinical Investigation, 93, 155–164.
- UEMATSU, T. and NAKASHIMA, M., 1994, Pharmacokinetic and pharmacodynamic properties of a novel xanthine oxidase inhibitor, BOF-4272, in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics, 270, 453–459.
- YAMAOKA, K., NAKAGAWA, T. and UNO, T., 1978, Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6, 547–558.